Literature DB >> 26996515

Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature.

Dian Winkelhorst1, Marije M Kamphuis1, Liselotte C de Kloet2, Jaap Jan Zwaginga3,4, Dick Oepkes1, Enrico Lopriore2.   

Abstract

BACKGROUND: The most feared bleeding complication in fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an intracranial hemorrhage (ICH). However, FNAIT may also lead to other severe bleeding problems. The aim was to analyze this spectrum and evaluate the occurrence of severe hemorrhages other than ICH in fetuses or neonates with FNAIT. STUDY DESIGN AND METHODS: A retrospective chart analysis of cases of FNAIT presenting with severe bleeding complications other than ICH at our institution from 1990 to 2015 was conducted. Additionally, a review of the literature was performed to identify case reports and case series on FNAIT presenting with extracranial hemorrhage.
RESULTS: Of 25 fetuses or neonates with severe bleeding due to FNAIT, three had isolated severe internal organ hemorrhage other than ICH, two pulmonary hemorrhages and one gastrointestinal hemorrhage. Two of these three neonates died due to this bleeding. Eighteen cases of extracranial bleeding complications as a first presentation of FNAIT were found in the literature, including ocular, gastrointestinal, spinal cord, pulmonary, renal, subgaleal, and genitourinary hemorrhages.
CONCLUSION: Bleeding complications other than ICH may be more extensive, and the presentation of FNAIT may have a greater spectrum than previously described. A high index of suspicion on the possible diagnosis of FNAIT with any bleeding complication in a fetus or neonate may enable adequate diagnostics, adequate treatment, and appropriate follow-up in future pregnancies, as is especially relevant for FNAIT.
© 2016 AABB.

Entities:  

Mesh:

Year:  2016        PMID: 26996515     DOI: 10.1111/trf.13550

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.

Authors:  Thijs W de Vos; Leendert Porcelijn; Suzanne Hofstede-van Egmond; Eva Pajkrt; Dick Oepkes; Enrico Lopriore; C Ellen van der Schoot; Dian Winkelhorst; Masja de Haas
Journal:  Br J Haematol       Date:  2021-08-16       Impact factor: 8.615

Review 2.  Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.

Authors:  Heidi Tiller; Anne Husebekk; Maria Therese Ahlen; Tor B Stuge; Bjørn Skogen
Journal:  Int J Womens Health       Date:  2017-04-19

3.  Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model.

Authors:  Mariana Eksteen; Gøril Heide; Heidi Tiller; Yan Zhou; Nora Hersoug Nedberg; Inigo Martinez-Zubiaurre; Anne Husebekk; Bjørn R Skogen; Tor B Stuge; Mette Kjær
Journal:  Reprod Biol Endocrinol       Date:  2017-04-21       Impact factor: 5.211

4.  A case report of prenatal diagnosis of fetal alloimmune thrombocytopenia: A CARE-compliant article.

Authors:  Jing Fu; Ruojin Yao; Wenjing Yong
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

5.  HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk.

Authors:  C Ellen van der Schoot; Masja de Haas; Dian Winkelhorst; Thijs W de Vos; Marije M Kamphuis; Leendert Porcelijn; Enrico Lopriore; Dick Oepkes
Journal:  BMJ Open       Date:  2020-07-20       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.